PHARMD, Director, Pharmacogenomics Center for Molecular Medicine NorthShore University HealthSystem
Dr. Dunnenberger is Director of Pharmacogenomics in the Center for Molecular Medicine at NorthShore University HealthSystem (NorthShore), and leads the various clinical pharmacogenomics implementation projects within the Center for Personalized Medicine. The goal of these projects is to improve the care and health outcomes of NorthShore University HealthSystem patients through pharmacogenomics-based strategies. He joined NorthShore in 2014. Dr. Dunnenberger leads the Pharmacogenomics Clinic, which serves as part of a system-wide initiative building upon the health system’s strong foundation in genetics and molecular medicine. The Clinic is among only a few across the country, and the first of its kind in the Chicagoland area that pre-emptively screens patients for responses to medications based on genetic makeup. His clinical expertise and research interests include translating pharmacogenomics into clinical practice, developing information technology solutions for delivering genetic information to both clinicians and patients in a practical manner, and evaluating methods for educating healthcare professionals about pharmacogenetics Dr. Dunnenberger has co-authored sixteen original publications, including several CPIC guidelines. He earned his PharmD from the University of Tennessee Health Science Center College of Pharmacy in 2012. He completed a PGY1 Pharmacy Practice Residency at Mission Hospital in Asheville, North Carolina, and a PGY2 Clinical Pharmacogenetics Residency in the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, Tennessee.
Implementing Pharmacogenomics in a Community Health System
This presentation will address key strategic and tactical decisions when implementing a clinic pharmacogenomics program. Using a community health system as a real world example, the audience will leave with practical knowledge they can apply at their workplace. Topics addressed will include necessary resources, laboratory testing, clinical decision support tools, and education.
Session Abstract – PMWC 2018 Michigan
Session Synopsis: Using pharmacogenomic data within the clinic is quickly becoming the standard of care for certain medication-gene pairs; and as research in pharmacogenomics continues to evolve, this data needs to be readily translated into clinic. Therefore, this session will outline some of this research and identify novel evidence based approaches being used to improve overall patient outcomes.